CIK 0001557746
- Non-accelerated filer
- Smaller reporting company
Aclaris Therapeutics, Inc.
Sign in to watch- Ticker
- ACRS
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 460571712
- Phone
- +1 484-324-7933
- Business address
- 701 LEE ROAD, SUITE 103, WAYNE, PA, 19087
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-03-01 | Balthaser Kevin Chief Financial Officer | Exercise or conversion | +2,375 | 188,130 | ||
| 2026-03-01 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −677 | $2.87 | $2K | 187,453 |
| 2026-03-01 | Balthaser Kevin Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −2,375 | 0 | ||
| 2026-02-03 | Balthaser Kevin Chief Financial Officer | Exercise or conversion | +22,025 | 192,204 | ||
| 2026-02-03 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −6,449 | $3.47 | $22K | 185,755 |
| 2026-02-03 | Balthaser Kevin Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −22,025 | 66,075 | ||
| 2026-02-02 | Balthaser Kevin Chief Financial Officer | Grant or award · Restricted Stock Units | +99,100 | 99,100 | ||
| 2026-02-02 | Balthaser Kevin Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +346,800 | 346,800 | ||
| 2026-02-01 | Balthaser Kevin Chief Financial Officer | Exercise or conversion | +14,750 | 175,163 | ||
| 2026-02-01 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −4,984 | $3.51 | $17K | 170,179 |
| 2026-02-01 | Balthaser Kevin Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −14,750 | 29,500 | ||
| 2026-01-02 | Balthaser Kevin Chief Financial Officer | Exercise or conversion | +13,200 | 164,874 | ||
| 2026-01-02 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −4,461 | $2.88 | $13K | 160,413 |
| 2026-01-02 | Balthaser Kevin Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −13,200 | 13,600 | ||
| 2026-01-01 | Balthaser Kevin Chief Financial Officer | Exercise or conversion | +7,500 | 153,924 | ||
| 2026-01-01 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −2,250 | $3.01 | $7K | 151,674 |
| 2026-01-01 | Balthaser Kevin Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −7,500 | 7,500 | ||
| 2025-12-31 | Balthaser Kevin Chief Financial Officer | Exercise or conversion | +73,750 | 166,358 | ||
| 2025-12-31 | Balthaser Kevin Chief Financial Officer | Shares withheld for taxes | −19,934 | $3.01 | $60K | 146,424 |
| 2025-12-31 | Balthaser Kevin Chief Financial Officer | Exercise or conversion · Restricted Stock Units | −73,750 | 0 |
Page 1 of 4 · 74 trades